Interestingly, C1q-mediated ADE tended to be more prominent than FcγR-mediated ADE in the patients with mild and moderate symptoms (numbers 47–95), compared to the convalescent-phase sera (numbers 26–46) (Table 2). The gene discussed is FCGR2A; the disease is acute disseminated encephalomyelitis.